Literature DB >> 330066

Crossreactivity with sporozoites, exoerythrocytic forms and blood schizonts of Plasmodium berghei in indirect fluorescent antibody tests with sera of rats immunized with sporozoites or infected blood.

J Golenser, J Heeren, J P Verhave, H J Kaay, J H Meuwissen.   

Abstract

IFA studies are reported using plasmodial antigens from three different stages of the life cycle of Plasmodium berghei: sporozoites (SP); exoerythrocytic schizonts in rat liver (EEF); and parasitized rat erythrocytes (SCH = schizonts). Two series of specific sera were applied: sera from adult rats with a blood-induced infection (series A) and sera from rats immunized against sporozoites by mosquito bites and protected against parasitaemia by chloroquine (series B). In series A antibody titres with all three antigens were seen, but those with SCH were generally the highest. Superinfection with parasitized rat blood did not change the titre. In series B sera, collected from rats after a single exposure to infected mosquitoes, showed only titres with SP from day 3 onwards, but after a second exposure titres to all three antigens developed. Crossreactivity with the heterologous antigens in series B was clearly less than in series A. Anti-P. berghei sporozoite antibodies did not crossreact with P. vivax sporozoites. Rats of series A were resistant to a challenge of parasitized blood and could also inhibit the development of sporozoites. Rats of series B were protected against a challenge of sporozoites but not of infected blood. The results are discussed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 330066      PMCID: PMC1541028     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  11 in total

1.  Plasmodium berghei berghei: irradiated sporozoites of the ANKA strain as immunizing antigens in mice.

Authors:  R L Beaudoin; C P Strome; T A Tubergen; F Mitchell
Journal:  Exp Parasitol       Date:  1976-06       Impact factor: 2.011

Review 2.  Sporozoite-induced immunity in mammalian malaria. A review.

Authors:  R S Nussenzweig; J Vanderberg; G L Spitalny; C I Rivera; C Orton; H Most
Journal:  Am J Trop Med Hyg       Date:  1972-09       Impact factor: 2.345

3.  Inactivity of rodent malaria anti-sporozoite antibodies against exoerythrocytic forms.

Authors:  J P Vanderberg
Journal:  Am J Trop Med Hyg       Date:  1973-09       Impact factor: 2.345

4.  Antibodies against sporozoites of human and simian malaria produced in rats.

Authors:  R S Nussenzweig; W Montuori; G L Spitalny; D Chen
Journal:  J Immunol       Date:  1973-02       Impact factor: 5.422

5.  Detection of early exoerythrocytic schizonts of Plasmodium cynomolgi by immunofluorescence.

Authors:  W A Krotoski; W E Collins; J R Jumper
Journal:  Am J Trop Med Hyg       Date:  1973-07       Impact factor: 2.345

6.  Specificity of protective immunity produced by x-irradiated Plasmodium berghei sporozoites.

Authors:  R S Nussenzweig; J P Vanderberg; H Most; C Orton
Journal:  Nature       Date:  1969-05-03       Impact factor: 49.962

7.  Relapse in malaria--an enigma.

Authors:  G R Coatney
Journal:  J Parasitol       Date:  1976-02       Impact factor: 1.276

8.  Plasmodium berghei: the spleen in sporozoite-induced immunity to mouse malaria.

Authors:  G L Spitalny; C I Rivera-Ortiz; R S Nussenzweig
Journal:  Exp Parasitol       Date:  1976-10       Impact factor: 2.011

9.  Parasitic protozoa of the blood of rodents: a revision of Plasmodium berghei.

Authors:  R Killick-Kendrick
Journal:  Parasitology       Date:  1974-10       Impact factor: 3.234

10.  Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei. V. In vitro effects of immune serum on sporozoites.

Authors:  J Vanderberg; R Nussenzweig; H Most
Journal:  Mil Med       Date:  1969-09       Impact factor: 1.437

View more
  6 in total

1.  Delayed-type hypersensitivity and protection in mice following immunization with Plasmodium berghei sporozoites.

Authors:  J P Verhave; G T Strickland
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

2.  CD8 T cell independent immunity after single dose infection-treatment-vaccination (ITV) against Plasmodium yoelii.

Authors:  Katherine L Doll; Noah S Butler; John T Harty
Journal:  Vaccine       Date:  2013-12-07       Impact factor: 3.641

Review 3.  Chemical Attenuation in the Development of a Whole-Organism Malaria Vaccine.

Authors:  Amber I Raja; Danielle I Stanisic; Michael F Good
Journal:  Infect Immun       Date:  2017-06-20       Impact factor: 3.441

4.  Blood-stage immunity to Plasmodium chabaudi malaria following chemoprophylaxis and sporozoite immunization.

Authors:  Wiebke Nahrendorf; Philip J Spence; Irene Tumwine; Prisca Lévy; William Jarra; Robert W Sauerwein; Jean Langhorne
Journal:  Elife       Date:  2015-02-25       Impact factor: 8.140

Review 5.  Novel approaches to whole sporozoite vaccination against malaria.

Authors:  Else M Bijker; Steffen Borrmann; Stefan H Kappe; Benjamin Mordmüller; Brandon K Sack; Shahid M Khan
Journal:  Vaccine       Date:  2015-10-23       Impact factor: 3.641

6.  Humanized DRAGA mice immunized with Plasmodium falciparum sporozoites and chloroquine elicit protective pre-erythrocytic immunity.

Authors:  Sai Majji; Wathsala Wijayalath; Soumya Shashikumar; Teodor D Brumeanu; Sofia Casares
Journal:  Malar J       Date:  2018-03-14       Impact factor: 2.979

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.